Arama Sonuçları - Jeffrey Perl
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 62
- Sonraki Sayfaya Git
-
1
Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral? Yazar: Edwina A. Brown, Jeffrey Perl
Baskı/Yayın Bilgisi 2020Carta -
2
Center-Centered in a Patient-Centered World? Yazar: Thyago Proença de Moraes, Jeffrey Perl
Baskı/Yayın Bilgisi 2016Carta -
3
Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’ Yazar: Jeffrey Perl, Mark L. Unruh, Christopher T. Chan
Baskı/Yayın Bilgisi 2006Revisão -
4
Practical Considerations When Prescribing Icodextrin: A Narrative Review Yazar: Samuel A. Silver, Ziv Harel, Jeffrey Perl
Baskı/Yayın Bilgisi 2014Revisão -
5
The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Yazar: Jeffrey Perl, Sharon J. Nessim, Joanne M. Bargman
Baskı/Yayın Bilgisi 2011Revisão -
6
-
7
Peritoneal Dialysis in Critically Ill Patients Yazar: Muthana Al Sahlawi, Daniela Ponce, David M. Charytan, Brett Cullis, Jeffrey Perl
Baskı/Yayın Bilgisi 2022Revisão -
8
The Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada Yazar: Louis‐Charles Desbiens, Karthik Tennankore, Jeffrey Perl, Christopher T. Chan, Annie‐Claire Nadeau‐Fredette
Baskı/Yayın Bilgisi 2025Artigo -
9
-
10
The risk of peritonitis after an exit site infection: a time-matched, case–control study Yazar: Alissa Lloyd, Navdeep Tangri, Leigh Anne Shafer, Claudio Rigatto, Jeffrey Perl, Paul Komenda, Manish M. Sood
Baskı/Yayın Bilgisi 2013Artigo -
11
Impact of Dialysis Modality on Survival after Kidney Transplant Failure Yazar: Jeffrey Perl, Omar Hasan, Joanne M. Bargman, Depeng Jiang, Yingbo Na, John S. Gill, Sarbjit V. Jassal
Baskı/Yayın Bilgisi 2011Artigo -
12
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis Yazar: Ziv Harel, Cameron Gilbert, Ron Wald, Chaim M. Bell, Jeffrey Perl, David N. Juurlink, Joseph Beyene, Prakesh S. Shah
Baskı/Yayın Bilgisi 2012Revisão -
13
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD Yazar: Ziv Harel, Michelle Sholzberg, Prakesh S. Shah, Katerina Pavenski, Shai Har-El, Ron Wald, Chaim M. Bell, Jeffrey Perl
Baskı/Yayın Bilgisi 2014Revisão -
14
Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis Yazar: Jenny I. Shen, Lucia Chen, Sitaram Vangala, Lynn Leng, Anuja Shah, Anjali Saxena, Jeffrey Perl, Keith C. Norris
Baskı/Yayın Bilgisi 2020Artigo -
15
-
16
Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study Yazar: Jeffrey Perl, J. Zhang, Brenda W. Gillespie, Björn Wíkström, Joan Fort, Takeshi Hasegawa, Douglas S. Fuller, R. Pisoni, Bruce Robinson, Francesca Tentori
Baskı/Yayın Bilgisi 2012Artigo -
17
Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival Yazar: Jeffrey Perl, Ron Wald, Philip A. McFarlane, Joanne M. Bargman, Edward F. Vonesh, Yingbo Na, Sarbjit V. Jassal, Louise Moist
Baskı/Yayın Bilgisi 2011Artigo -
18
A Palliative Approach to Dialysis Care Yazar: Vanessa Grubbs, Alvin H. Moss, Lewis M. Cohen, Michael J. Fischer, Michael J. Germain, Sarbjit V. Jassal, Jeffrey Perl, Daniel E. Weiner, Rajnish Mehrotra
Baskı/Yayın Bilgisi 2014Artigo -
19
The Risk of Major Hemorrhage with CKD Yazar: Amber O. Molnar, Sarah E. Bota, Amit X. Garg, Ziv Harel, Ngan N. Lam, Eric McArthur, Gihad Nesrallah, Jeffrey Perl, Manish M. Sood
Baskı/Yayın Bilgisi 2016Artigo -
20
Hospitalizations in Dialysis Patients in Canada: A National Cohort Study Yazar: Amber O. Molnar, Louise Moist, Scott Klarenbach, Jean‐Philippe Lafrance, Soojin Kim, Karthik Tennankore, Jeffrey Perl, Joanne Kappel, Michael Terner, Jagbir Gill, Manish M. Sood
Baskı/Yayın Bilgisi 2018Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Dialysis
Peritoneal dialysis
Intensive care medicine
Hemodialysis
Surgery
Environmental health
Nursing
Confidence interval
Disease
Population
Health care
Political science
Family medicine
Hazard ratio
Kidney disease
Law
Renal replacement therapy
Cohort
Coronavirus disease 2019 (COVID-19)
Economic growth
Economics
Infectious disease (medical specialty)
Proportional hazards model
Nephrology
Peritonitis
Transplantation
Biology
Pandemic